Effect of Advanced Glycation End Products on Human Thyroglobulin’s Antigenicity as Identified by the Use of Sera from Patients with Hashimoto’s Thyroiditis and Gestational Diabetes Mellitus

Table 2

Average values ± SD of the parameters (age, HbA1c and aTgAbs, and aTPOAbs serum levels) in the group of patients with gestational diabetes mellitus (GDM), Hashimoto’s thyroiditis (HT), and healthy controls (HC).

	GDM; ()	HT; ()	HC; ()
Age (years)	34.2 ± 4.6	43.6 ± 15.5	29.4 ± 6.5
HbA1c%	5.4 ± 0.5	4.7 ± 0.4	4.6 ± 0.4
aTgAbs (IU/mL)	425.3 ± 455	1941.5 ± 983	<70
aTPOAbs (IU/mL)	236.66 ± 172.93	39311.11 ± 29359	<60